drugset / Trial / NCT07285122
Inhaled RB042 in Healthy Adult Volunteers and Healthy Adult Smokers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 3-part, randomised, double-blind, placebo-controlled, first in human study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of inhaled RB042.
Timeline
- Start
- 2026-02-16
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RB042 | Unknown | — | Inhaled |
Indications
No indication recorded.